In October, Abbott’s board of directors authorized a new share repurchase program of up to $7B of the company’s common shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT:
- Abbott reports Q3 adjusted EPS $1.21, consensus $1.20
- Abbott narrows FY24 adjusted EPS view to $4.64-$4.70 from $4.61-$4.71
- Abbott sees Q4 adjusted EPS $1.31-$1.37, consensus $1.34
- Abbott reports Q3 Worldwide Medical Devices sales up 11.7% on reported basis
- Options Volatility and Implied Earnings Moves Today, October 16, 2024
Questions or Comments about the article? Write to editor@tipranks.com